Wesfarmers (ASX: WES) – Wesfarmers Reports 2026 Full-Year Results

Henry Fung

Henry is a co-founder of MF & Co. Asset Management with over 20 years in financial services as a trader and investor, including the past 10 years advising clients and building quantitative trading systems. Henry also maintains a high conviction list of 5 stocks that you can get for free and has a free 5-day course on how professionals use quantitative strategies to find an edge. The concepts in the course are applied in the Quantitative Leveraged ETF L/S Strategy.


August 27, 2026

Wesfarmers (ASX: WES)View stock profile →

Wesfarmers Limited delivered mixed financial results for the full year ended 30 June 2026, with net profit after tax of 2,874 million dollars. Stripping out significant items from the prior period, underlying net profit after tax expanded 8.3 percent, demonstrating operational resilience despite revenue declining 1.8 percent to 47.3 billion dollars. The earnings growth reflects management’s disciplined approach to navigating cost inflation and softer consumer conditions, with pricing actions and productivity initiatives offsetting margin pressures.

The underlying earnings expansion was supported by strong contributions from the group’s hardware and retail anchors. Bunnings maintained solid trading momentum, with its established value proposition continuing to drive sales and earnings growth across varying market conditions. Kmart Group delivered higher earnings supported by strong performance of its Anko private label range and improved cost discipline, while both divisions benefited from accelerated digital channel penetration and expanded product ranges designed to drive customer engagement.

Wesfarmers Chemical, Energy and Fertilisers delivered mixed outcomes. While ammonia pricing faced headwinds from Middle East conflict dynamics, the division offset this through improved operational performance and strengthening contributions from its lithium business. Spodumene concentrate production reached 209,000 tonnes, exceeding both guidance and nameplate capacity, demonstrating strong operational execution. However, the lithium refinery ramp-up faced intermittent odour issues throughout the year, with mitigation measures commenced in late financial year 2026. This remains an important watch point for future guidance.

Wesfarmers Health demonstrated tangible momentum from its multi-year transformation, with strong network growth in Priceline Pharmacy and improved competitive performance in wholesale operations in an increasingly crowded market. Industrial and Safety saw underlying earnings growth driven by higher sales and improved productivity at Blackwoods. Officeworks remained weighed by one-off transformation costs as the division transitions to a lower-cost operating model and refreshed customer value proposition, with management flagging this investment as temporary ahead of expected long-term earnings recovery.

Earnings per share declined 1.8 percent to 253.4 cents, while operating cash flow moderated to 4.3 billion dollars from 4.6 billion dollars in the prior year. The cash flow decline warrants monitoring given the group’s capital intensity and ongoing dividend commitments.

Our Exclusive Top 5 Stock Picks

Five high conviction stocks that didn't make the public list. Backed by institutional research with significant upside potential. Subscribe for free access.

Invalid email address
By subscribing, you consent to receive communications from us. You can unsubscribe at any time.

For investors, the result demonstrates that Wesfarmers’ diversified portfolio can generate earnings growth even as Australian households face structural cost-of-living headwinds. The key watch points are execution of Officeworks’ transformation program, progress of the lithium refinery ramp-up at WesCEF, and sustainability of retail market share gains amid intensifying competitive pressures. The announcement is price sensitive and has been classified as a material announcement by the ASX.

View the full ASX announcement (PDF)

About Wesfarmers Limited (ASX: WES)

Wesfarmers is a diversified Australian conglomerate with operations in retail, chemicals, fertilisers, and industrial safety. Its portfolio includes Bunnings, Kmart, Target, and Officeworks.

If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.

This is general advice only. MF & Co Asset Management has not considered your personal financial needs, objectives or current situation. This information is not an offer, solicitation, or a recommendation for any financial product unless expressly stated. You should seek professional investment advice before making any investment decision.

You May Also Like…

Subscribe

Want more Free Research?

Subscribe today for free and get an alert when we have new research and webinars.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

MF & Co. Asset Management

MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.

We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.

Contact

Get In Touch

Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm

Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000

 

Share This